Health risks after cessation of postmenopausal hormone therapy.
Pines
Amos
A
Department of Internal Medicine T, Ichilov Hospital, 6 Weizman Street, Tel Aviv 64239, Israel.
Sturdee
David
D
Birkhäuser
Martin
M
D000367:Age Factors; D001943:Breast Neoplasms / Q000139:chemically induced*; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000453:epidemiology / Q000517:prevention & control; D017698:Postmenopause; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012307:Risk Factors; D013923:Thromboembolism / Q000139:chemically induced; D016387:Women's Health